Oral Drug Delivery Resources

  1. Innovative Softgel Technologies To Deliver Poorly Soluble Molecules

    Learn how to expedite the development pathway for early phase compounds and how lipid based formulations provide an innovative approach to enhance bioavailability for challenging molecules.

  2. How Approved Drugs Have Evolved Since The '70s

    Drugs have become more lipophilic and complex in structure over time. Innovative strategies are needed to improve the bioavailability of these new drugs.

  3. Layer By Layer: 3D Screen Printing And The Future Of Drug Development 8/15/2025

    3D screen printing can produce tablets across a range of release profiles, from conventional immediate release tablets to multi-compartment drug delivery systems that mix different release profiles.

  4. Accelerating The Development Of Oncology Medicines 3/3/2022

    Oncology drug development has seen a significant shift in focus, as molecule chemistries and drug technologies have improved. Explore five areas for consideration and the potential emerging solutions.

  5. Developing An Effective Lipid Nanoparticle Formulation Process For Small Molecule And Biologicals Delivery 3/1/2022

    Lipid nanoparticles (LNPs) are a versatile formulation technology used by drug development teams to deliver a variety of small/large molecules, peptides, and biologicals.

  6. Formulation Development Strategy For Early Phase Human Studies 1/27/2022

    Determining bioavailable formulation for animal PK, GLP toxicity, first-in-human, and first-in-patient is challenging. Drug delivery systems are usually used for poorly soluble and bioavailable compounds.

  7. Integrated Strategies for Achieving Regulatory Milestones Faster 10/12/2023

    Learn how an innovative formulation platform reduced development timelines and allowed a sponsor to find the optimal nafamostat formulation without adding unnecessary delays.

  8. Liquid Capsule Manufacturing: What To Know 5/4/2022

    Capsules surround a drug in an unflavored, solid barrier enclosure. This article focuses on liquid capsule manufacturing and its advantages.

  9. Closing The Duration Gap In FDA-Approved Long-Acting Contraceptives 7/17/2024

    A gap exists between three months and three years in FDA-approved long-acting contraceptives (LACs). A microsphere formulation enables sustained release over a six to twelve-month period.

  10. The Role Of Micronization In The Journey To Drug Product Development

    Micronization is an incredibly important step of the process of transitioning a compound from initial discovery into the clinic. Learn more about the key benefits of micronization.